TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change scores of Timed up-and-go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Change scores of dual task Timed up-and-go test (manual)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Health Literacy Scale for Acute Complications of Diabetes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence rate of axial length shortening greater than 0.05 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood loss intraoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: level of luteinizing hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: level of follicle stimulating hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: level of testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Visual analogue pain score (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oxidative stress biomarkers levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in proinflammatory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in anti-inflammatory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to clinical improvement (NEWS2 score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of digit replantation or revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Multiple Sclerosis Quality of Life-MuSiQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: One-year second treatment-free remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Development of auto antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinical diagnosis of an autoimmune condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in peripheral capillary oxygen saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in airflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in chest plethysmography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in abdomen plethysmography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in masticatory muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-calcified plaque volume (NCPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total plaque volume (TPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients who decide to enroll
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Composite of hospitalizations due to worsening heart failure and/or acute intravenous administrations of diuretics or inotropic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: alpha diversity composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbial community composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathogenic strain of bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Survival at 14 Days
Endpoint domain: Mortality/survival
Primary endpoint: Survival at 7 Days
Endpoint domain: Mortality/survival
Primary endpoint: Change in the number of wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of MASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of hydration, TEWL, viscoelasticity, or melanin and erythema index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Nebivolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUCt of Nebivolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax of DWN12088
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUCt of DWN12088
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change from Baseline in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Healthcare cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of pain among breast cancer survivors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of related adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: General attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attention shifting
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Blood Sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cycling Protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stork Balance Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular Endurance: Push-ups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Illinois Agility Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective PFO closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accelerometer outputs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User Experience Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical complete remission rate (cCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time averaged change in Lp(a)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse Event of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Symptomatic Bacteremia With Positive L. Reuteri Identification
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate in Investigator's Global Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in minimal residual disease (MRD) negativity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flow rates variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in implants clinical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of children healed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of quit attempts
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: urinary retention incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Short-interval intracortical inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Full recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of participants with adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma Leptin levels changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma Ghrelin levels changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma insulin levels changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Symptoms of PTSD Indicated by the PTSD Checklist for DSM-5 scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine-induced humoral immune responses to the Ebola virus glycoprotein (EBOV GP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of dialysis treatments completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area Under the Plasma Concentration-Time Curve from Zero to the Last Measurable Concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve from Zero Extrapolated to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anisotropy Score (FA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Radial diffusion rate (RD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Apparent dispersion coefficient (ADC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Magnetization transfer ratio (MTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SRS Score 2 (Social Response Scale 2) score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Peabody (Motion Estimation Timewarp) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastrointestinal disease states
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference of Standard Deviation of NN Intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Normalized logMAR Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of required training
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Child's fear level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total Duration of Arthrocentesis Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Slow sleep spindle density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slow sleep spindle amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fast sleep spindle density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fast sleep spindle amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crying and fussing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analyses of b- and t-cells development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: bleeding requiring blood transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Number of practices that adopt team-based care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 24-hour glucose regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Toxicity (Grade 3 or worse)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of urine loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 7-day abstinence from smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D knee kinematic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of guided surgical actions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Gastroesophageal Reflux Disease Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CT features of interrupted suprarenal inferior vena cava
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk control measure scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite number of hospital admissions for Heart Failure
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Presence of MDM2 amplification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hematocrit to Hemoglobin Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Red Blood Cell Distribution Width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adoption of group MCT
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number and Proportion of Established Users
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and Proportion of Established Users who reduce their CPD consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Descriptive weekly average CPD consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restoration of visual perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of execution of the WHO surgical safety checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to Apply Intervention by clinician
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Sensory (Pain) Assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of Compression Therapy System Prototype compared to Interface Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue Severity Scale (score)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: FLAAC behavioral scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of New Disease Genes Discovered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Expanded Disease Gene Phenotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Children Attending ECE
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Progressive Aerobic Cardiovascular Endurance Run (PACER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total treatment duration and cycle for Palbociclib
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: frequency of regional and systemic metabolic PET/CT changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FDG intensity of regional and systemic metabolic PET/CT changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fibromyalgia Impact Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety of AVD-104
Endpoint domain: Adverse events/effects
Primary endpoint: Intraclass correlation coefficient between ultrasound and MRI measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RF cross-sectional area (CSA) at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Strength - Medical Research Council Sum-score (MRC-ss) at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life testing using EuroQol Group 5-dimension 5-level (EQ-5D-5L) questionnaire at post-discharge outpatient visit
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total number of rescue analgesic applications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Student Satisfaction and Self-Confidence Scale in Learning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-efficacy scale in monitoring and management of electronic fetal monitoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Incidence of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-Emergent Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: three years mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in cytokine IL-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Serious Adverse Event(s) (SAEs) Considered Related to Study Drug Administration
Endpoint domain: Adverse events/effects
Primary endpoint: Score on Geriatric Depression Scale (GDS-15)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Score on Beck Anxiety Inventory (BAI) Report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Score on EuroQol Questionnaire Global quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Depression Anxiety Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Philadelphia Mindfulness Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity to Punishment and Sensitivity to Reward Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Care engagement failure
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Re-engagement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Dropouts
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of 68Ga-DOTA-FAPI PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of 68Ga-DOTA-FAPI PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in presence of a detailed risk-reduction plan
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in number of evidence-based prevention strategies being used over time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in willingness to use evidence-based prevention strategies over time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in intention to use evidence-based prevention strategies over time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients treated with mechanical thrombectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: SARS-CoV-2 detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Severe Maternal Morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Consented Compared to Number of Recruitment Letters Sent
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Completed the Intervention Compared to Number of Participants Consented
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Level of O2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Level of CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Level of SaO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time until completion of tissue expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Dry Eye Sign Using Ocular Surface Scale (OSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Reported Symptom
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relapse probability
Endpoint domain: Mortality/survival
Primary endpoint: Immediate Post-Concussion Assessment and Cognitive Testing score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Step symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) of Eicosapentaonic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve (AUC) of Fucoxanthin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve (AUC) of B-Carotin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Plasma Concentration [Cmax] of Eicosapentaonic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Plasma Concentration [Cmax] of Fucoxanthin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: First time of rescue analgesia requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Diagnosis of advanced hepatic fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Shear wave elastography assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes